Identification of a novel SEREX antigen family, ECSA, in esophageal squamous cell carcinoma

Proteome Science

Volumn 9, Issue , 2011, Pages

  Kagaya, Akiko ^a   Shimada, Hideaki ^b   Shiratori, Tooru ^a   Kuboshima, Mari ^a   Nakashima Fujita, Kazue ^a   Yasuraoka, Mari ^a   Nishimori, Takanori ^a   Kurei, Shunsuke ^b   Hachiya, Takahisa ^c   Murakami, Akihiro ^c   Tamura, Yutaka ^a   Nomura, Fumio ^a   Ochiai, Takenori ^d   Matsubara, Hisahiro ^a   Takiguchi, Masaki ^a   Hiwasa, Takaki ^a  

^a CHIBA UNIVERSITY   (Japan)

^b TOHO UNIVERSITY   (Japan)

^c Medical & Biological Laboratories Co Ltd   (Japan)

^d Gastroenterological Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; TUMOR MARKER;

ADULT; AGED; AMINO ACID SEQUENCE; ANTIBODY BLOOD LEVEL; ANTIGEN EXPRESSION; ARTICLE; CANCER TISSUE; CONTROLLED STUDY; DNA LIBRARY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL CARCINOMA SEREX ANTIGEN FAMILY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; MULTIGENE FAMILY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

EID: 79959337521     PISSN: None     EISSN: 14775956     Source Type: Journal    
DOI: 10.1186/1477-5956-9-31     Document Type: Article

References (33)

1. Isono K, Ochiai T. Recent advances of treatment of cancer of the esophagus (review). Ann Cancer Res Therapy 1992, 1:9-16.
2. Shimada H, Nabeya Y, Okazumi S, Matsubara H, Shiratori T, Gunji Y, Kobayashi S, Hayashi H, Ochiai T. Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma. Surgery 2003, 133:486-494. 10.1067/msy.2003.139, 12773976.
3. Daly JM, Karnell LH, Menck HR. National cancer data base report on esophageal carcinoma. Cancer 1996, 78:1820-1828. 10.1002/(SICI)1097-0142(19961015)78:8<1820::AID-CNCR25 3.0.CO;2-Z, 8859198.
4. Shimada H, Kitabayashi H, Nabeya Y, Okazumi S, Matsubara H, Funami Y, Miyazawa Y, Shiratori T, Uno T, Itoh H, Ochiai T. Treatment response and prognosis of patients after recurrence of esophageal cancer. Surgery 2003, 133:24-31. 10.1067/msy.2003.31, 12563234.
5. Kim YH, Ajani JA, Ota DM, Lunch P, Roth JA. Value of serial carcinoembryonic antigen levels in patients with resectable adenocarcinoma of the esophagus and stomach. Cancer 1995, 75:451-456. 10.1002/1097-0142(19950115)75:2<451::AID-CNCR2820750207 3.0.CO;2-U, 7812915.
6. Munck-Wikland E, Kuylenstierna R, Wahren B, Lindholm J, Haglund S. Tumor markers carcinoembryonic antigen, CA 50, and CA 19-9 and squamous cell carcinoma of the esophagus. Pretreatment screening. Cancer 1988, 62:2281-2286. 10.1002/1097-0142(19881201)62:11<2281::AID-CNCR2820621102 3.0.CO;2-1, 3179942.
7. McKnight A, Mannell A, Shperling I. The role of carbohydrate antigen 19-9 as a tumour marker of oesophageal cancer. Br J Cancer 1989, 60:249-251. 10.1038/bjc.1989.263, 2247033, 2765375.
8. Foley EJ. Attempts to induce immunity against mammary adenocarcinoma in inbred mice. Cancer Res 1953, 13:578-580.
9. Prehn RT, Main JM. Immunity to methylcholanthrene-induced sarcomas. J Natl Cancer Inst 1957, 18:769-778.
10. Sahin U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I, Pfreundschuh M. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 1995, 92:11810-11813. 10.1073/pnas.92.25.11810, 40492, 8524854.
11. Cancer immunome database. , http://www2.licr.org/CancerImmunomeDB/
12. Chen YT, Scanlan MJ, Sahin U, Türeci O, Gure AO, Tsang S, Williamson B, Stockert E, Pfreundschuh M, Old LJ. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 1997, 94:1914-1918. 10.1073/pnas.94.5.1914, 20017, 9050879.
13. Shimada H, Takeda A, Arima M, Okazumi S, Matsubara H, Nabeya Y, Funami Y, Hayashi H, Gunji Y, Suzuki T, Kobayashi S, Ochiai T. Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma. Cancer 2000, 89:1677-1683. 10.1002/1097-0142(20001015)89:8<1677::AID-CNCR5 3.0.CO;2-9, 11042560.
14. Shimada H, Nakajima K, Ochiai T, Koide Y, Okazumi SI, Matsubara H, Takeda A, Miyazawa Y, Arima M, Isono K. Detection of serum p53 antibodies in patients with esophageal squamous cell carcinoma: correlation with clinicopathologic features and tumor markers. Oncol Rep 1998, 5:871-874.
15. Shimada H, Nabeya Y, Okazumi S, Matsubara H, Funami Y, Shiratori T, Hayashi H, Takeda A, Ochiai T. Prognostic significance of serum p53 antibody in patients with esophageal squamous cell carcinoma. Surgery 2002, 132:41-47. 10.1067/msy.2002.125307, 12110794.
16. Nakashima K, Shimada H, Ochiai T, Kuboshima M, Kuroiwa N, Okazumi S, Matsubara H, Nomura F, Takiguchi M, Hiwasa T. Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma. Int J Cancer 2004, 112:1029-1035. 10.1002/ijc.20517, 15386348.
17. Shimada H, Nakashima K, Ochiai T, Nabeya Y, Takiguchi M, Nomura F, Hiwasa T. Serological identification of tumor antigens of esophageal squamous cell carcinoma. Int J Oncol 2005, 26:77-86.
18. Kuboshima M, Shimada H, Liu TL, Nakashima K, Nomura F, Takiguchi M, Hiwasa T, Ochiai T. Identification of a novel SEREX antigen, SLC2A1/GLUT1, in esophageal squamous cell carcinoma. Int J Oncol 2006, 28:463-468.
19. Kuboshima M, Shimada H, Liu TL, Nomura F, Takiguchi M, Hiwasa T, Ochiai T. Presence of serum TRIM21 antibodies in patients with esophageal squamous cell carcinoma. Cancer Sci 2006, 97:380-386. 10.1111/j.1349-7006.2006.00192.x, 16630135.
20. Hiwasa T, Shimada H, Ochiai T, Takiguchi M. Serological identification of antigens by recombinant cDNA expression cloning (SEREX) using antibodies from patients with esophageal squamous cell carcinoma. Moleculomics and Thereafter 2006, 99-117. Kerala, India: Research Signpost, Hiwasa T.
21. Shimada H, Kuboshima M, Shiratori T, Nabeya Y, Takeuchi A, Takagi H, Nomura F, Takiguchi M, Ochiai T, Hiwasa T. Serum anti-myogegalin antibodies in patients with esophageal squamous cell carcinoma. Int J Oncol 2007, 30:97-103.
22. Shiratori T, Shimada H, Kagaya A, Kuboshima M, Nabeya Y, Machida T, Goto K, Takiguchi M, Ochiai T, Hiwasa T. Sensitization against anticancer drugs by transfection with UBE2I variant gene into ras-NIH3T3 mouse fibroblasts. Anticancer Res 2007, 27:3227-3234.
23. Hiwasa T, Shimada H, Kuboshima M, Shiratori T, Kagaya A, Nabeya Y, Sugano S, Ochiai T, Matsubara H, Takiguchi M. Decrease in chemosensitivity against anticancer drugs by an esophageal squamous cell carcinoma SEREX antigen, AISEC. Int J Oncol 2009, 34:641-648.
24. Shimada H, Kagaya A, Shiratori T, Nomura F, Takiguchi M, Matsubara H, Hiwasa T. Detection of anti-CUEC-23 antibodies in serum of patients with esophageal squamous cell carcinoma-possible new serum marker for esophageal cancer-. J Gastroenterology 2009, 44:691-696.
25. Shimada H, Shiratori T, Yasuraoka M, Kagaya A, Kuboshima M, Nomura F, Takiguchi M, Ochiai T, Matsubara H, Hiwasa T. Identification of Makorin 1 as a novel SEREX antigen of esophageal squamous cell carcinoma. BMC Cancer 2009, 9:232. 10.1186/1471-2407-9-232, 2722670, 19604354.
26. Tureci O, Sahin U, Zwick C, Koslowski M, Seitz G, Pfreundschuh M. Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens. Proc Natl Acad Sci USA 1998, 95:5211-5216. 10.1073/pnas.95.9.5211, 20240, 9560255.
27. Nesterova M, Johnson N, Xheadle C, Cho-Chung YS. Autoantibody biomarker opens a new gateway for cancer diagnosis. Biochim Biophys Acta 2006, 1762:398-403.
28. Kasid U, Pfeifer A, Brennan T, Beckett M, Weichselbaum RR, Dritschilo A, Mark GE. Effect of antisense c-raf-1 on tumorigenicity and radiation sensitivity of a human squamous carcinoma. Science 1989, 243:1354-1356. 10.1126/science.2466340, 2466340.
29. Takahashi K, Kanazawa H, Chan H, Hosono T, Takahara M, Sato K. A case of esophageal carcinoma metastatic to the mandible and characterization of two cell lines (T.T. and T.Tn.). Jpn J Oral Maxillofac Surg 1990, 36:307-316.
30. Shimada H, Shimizu T, Ochiai T, Liu TL, Sashiyama H, Nakamura A, Matsubara H, Gunji Y, Kobayashi S, Tagawa M, Sakiyama S, Hiwasa T. Preclinical study of adenoviral p53 gene therapy for esophageal cancer. Surg Today 2001, 31:597-604. 10.1007/s005950170093, 11495154.
31. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
32. Sobin LH, Wittekind CH, . (Eds) UICC TNM Classification of malignant tumors. 2000, New York, John Wiley & Sons, 6, (Eds).
33. Laemmli U. Cleavage of structural proteins during the assembly of the head of bacteriophage. Nature 1970, 227:680-685. 10.1038/227680a0, 5432063.